Gan & Lee Pharmaceuticals. (SHA:603087)
China · Delayed Price · Currency is CNY 58.10
-1.54 (-2.58%)
Jul 25, 2025, 2:45 PM CST
SHA:603087 Revenue
Gan & Lee Pharmaceuticals. had revenue of 984.87M CNY in the quarter ending March 31, 2025, with 75.76% growth. This brings the company's revenue in the last twelve months to 3.47B, up 32.93% year-over-year. In the year 2024, Gan & Lee Pharmaceuticals. had annual revenue of 3.05B with 16.77% growth.
Revenue (ttm)
3.47B
Revenue Growth
+32.93%
P/S Ratio
10.03
Revenue / Employee
661.56K
Employees
5,245
Market Cap
34.79B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 3.05B | 437.31M | 16.77% |
| Dec 31, 2023 | 2.61B | 895.77M | 52.31% |
| Dec 31, 2022 | 1.71B | -1.90B | -52.60% |
| Dec 31, 2021 | 3.61B | 250.16M | 7.44% |
| Dec 31, 2020 | 3.36B | 466.82M | 16.12% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Jiangsu Hengrui Medicine | 29.19B |
| Shenzhen Mindray Bio-Medical Electronics | 35.59B |
| WuXi AppTec | 39.59B |
| Sichuan Biokin Pharmaceutical | 5.82B |
| Zhangzhou Pientzehuang Pharmaceutical., | 10.76B |
| Aier Eye Hospital Group | 21.81B |
| Shanghai United Imaging Healthcare | 10.43B |
| Yunnan Baiyao Group Co.,Ltd | 40.10B |